Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early mycophenolate mofetil in newly diagnosed anti-dsDNA-high SLE
ChiCTR1800017540Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate mofetil in systemic lupus erythematosus (SLE) (2 arms), sponsored by Ruijin Hospital. Primary endpoint: Proportion of patients with flare at week 96. Started Sep 2018; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on ChiCTR1800017540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017540.